BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34051683)

  • 1. Combined dynamic contrast enhanced MRI parameter with clinical factors predict the survival of concurrent chemo-radiotherapy in patients with 2018 FIGO IIICr stage cervical cancer.
    Qin F; Pang H; Ma J; Zhao M; Jiang X; Tong R; Yu T; Luo Y; Dong Y
    Eur J Radiol; 2021 Aug; 141():109787. PubMed ID: 34051683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
    Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
    BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Added-value of texture analysis of ADC in predicting the survival of patients with 2018 FIGO stage IIICr cervical cancer treated by concurrent chemoradiotherapy.
    Zhang X; Zhang Q; Guo J; Zhao J; Xie L; Zhang J; An J; Yu X; Zhao X
    Eur J Radiol; 2022 May; 150():110272. PubMed ID: 35334244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of multiparametric MRI combined with clinical prognostic parameters in predicting the 5-year survival of stage IIIC1 cervical squamous cell carcinoma.
    Qin F; Pang H; Ma J; Xu H; Yu T; Luo Y; Dong Y
    Eur J Radiol; 2023 Dec; 169():111181. PubMed ID: 37939604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Added-value of dynamic contrast-enhanced MRI on prediction of tumor recurrence in locally advanced cervical cancer treated with chemoradiotherapy.
    Zhang Q; Guo J; Ouyang H; Chen S; Zhao X; Yu X
    Eur Radiol; 2022 Apr; 32(4):2529-2539. PubMed ID: 34647177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic values of ADC
    Akkus Yildirim B; Onal C; Erbay G; Cem Guler O; Karadeli E; Reyhan M; Koc Z
    J Obstet Gynaecol; 2019 Feb; 39(2):224-230. PubMed ID: 30354907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.
    Lin G; Yang LY; Lin YC; Huang YT; Liu FY; Wang CC; Lu HY; Chiang HJ; Chen YR; Wu RC; Ng KK; Hong JH; Yen TC; Lai CH
    Eur Radiol; 2019 Feb; 29(2):556-565. PubMed ID: 30051142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of apparent diffusion coefficient in neuroendocrine carcinomas of the uterine cervix.
    Chen J; Ma N; Sun M; Chen L; Yao Q; Chen X; Lin C; Lu Y; Lin Y; Lin L; Fan X; Chen Y; Wu J; He H
    PeerJ; 2023; 11():e15084. PubMed ID: 37020850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of early response to concurrent chemoradiotherapy in cervical cancer: Value of multi-parameter MRI combined with clinical prognostic factors.
    Zheng X; Guo W; Dong J; Qian L
    Magn Reson Imaging; 2020 Oct; 72():159-166. PubMed ID: 32621877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole lesion histogram analysis of apparent diffusion coefficients on MRI predicts disease-free survival in locally advanced squamous cell cervical cancer after radical chemo-radiotherapy.
    Zhao B; Cao K; Li XT; Zhu HT; Sun YS
    BMC Cancer; 2019 Nov; 19(1):1115. PubMed ID: 31729974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging to predict neoadjuvant chemotherapy effect in FIGO stage IB2-IIA2 cervical cancers.
    Zhang A; Song J; Ma Z; Chen T
    Radiol Med; 2020 Dec; 125(12):1233-1242. PubMed ID: 32424659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced MRI histogram parameters predict progression-free survival in patients with advanced esophageal squamous carcinoma receiving concurrent chemoradiotherapy.
    Xu L; Ge X; Sun N; Liu X
    Acta Radiol; 2020 Oct; 61(10):1316-1325. PubMed ID: 32053003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of lymph node dissection on stage IIICr of cervical cancer before CCRT: study protocol for a phase III, randomized controlled clinical trial (CQGOG0103).
    He M; Guo M; Zhou Q; Tang Y; Zhong L; Liu Q; Fan X; Zhao X; Zhang X; Chen G; Shen Y; Xu Q; Chen X; Li Y; Zou D
    J Gynecol Oncol; 2023 May; 34(3):e55. PubMed ID: 36998225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in women with cervical cancer stage IIIC1r treated with concurrent chemoradiotherapy.
    Ryu JM; Choi YS; Bae JY
    J Obstet Gynaecol Res; 2020 Jul; 46(7):1165-1172. PubMed ID: 32428977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET/MRI in Cervical Cancer: Associations Between Imaging Biomarkers and Tumor Stage, Disease Progression, and Overall Survival.
    Shih IL; Yen RF; Chen CA; Cheng WF; Chen BB; Chang YH; Cheng MF; Shih TT
    J Magn Reson Imaging; 2021 Jan; 53(1):305-318. PubMed ID: 32798280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DCE-MRI-Derived Volume Transfer Constant (K
    Ye ZM; Dai SJ; Yan FQ; Wang L; Fang J; Fu ZF; Wang YZ
    Technol Cancer Res Treat; 2018 Jan; 17():1533034618765254. PubMed ID: 29642773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Multiparametric Magnetic Resonance Imaging in the Study of Primary Tumor and Pelvic Lymph Node Metastasis in Stage IB1-IIA1 Cervical Cancer.
    Zhang X; Dong Y; Song Q; Zhu Y; Pang H; Luo Y; Yu T; Liu F; Guo Y
    J Comput Assist Tomogr; 2020; 44(5):750-758. PubMed ID: 32842062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy.
    Onal C; Erbay G; Guler OC
    J Magn Reson Imaging; 2016 Oct; 44(4):1010-9. PubMed ID: 26919800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R; Zhang H; Zou L; Qu Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of ADC quantification for clinical outcome in uterine cervical cancer treated with concurrent chemoradiotherapy.
    Gu KW; Kim CK; Choi CH; Yoon YC; Park W
    Eur Radiol; 2019 Nov; 29(11):6236-6244. PubMed ID: 30980126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.